Abstract
The involvement of microRNAs in human cancer is now well established. A few miRNAs function as oncogenes and many others display tumor suppressor activities. Several studies in the past few years have highlighted and reinforced a role for miR-203 as a tumor suppressor microRNA. This collection of in vitro studies give an initial and stimulating look into the many different means by which miR-203 can inhibit the various pathways involved in cell transformation and metastasis. Of special relevance is the ability of miR-203 to prevent proliferation of progenitor cells as well the epithelial-to-mesenchymal transition frequently associated with cancer progression and metastasis. Further more, the breadth of cancer types examined in these studies implicates miR-203 as a potential tumor suppressor gene whose reexpression or re-introduction into malignant cells could, by nature of its inherent pleiotropic effects as a miRNA, represent an important therapeutic tool used to combat a multitude of human cancers.
Keywords: Cell proliferation, microRNA, oncogenesis, progenitor cell, stemness, tumor suppression.
MicroRNA
Title:MicroRNA-203: Tumor Suppression and Beyond
Volume: 2 Issue: 2
Author(s): Carlos I. Michel and Marcos Malumbres
Affiliation:
Keywords: Cell proliferation, microRNA, oncogenesis, progenitor cell, stemness, tumor suppression.
Abstract: The involvement of microRNAs in human cancer is now well established. A few miRNAs function as oncogenes and many others display tumor suppressor activities. Several studies in the past few years have highlighted and reinforced a role for miR-203 as a tumor suppressor microRNA. This collection of in vitro studies give an initial and stimulating look into the many different means by which miR-203 can inhibit the various pathways involved in cell transformation and metastasis. Of special relevance is the ability of miR-203 to prevent proliferation of progenitor cells as well the epithelial-to-mesenchymal transition frequently associated with cancer progression and metastasis. Further more, the breadth of cancer types examined in these studies implicates miR-203 as a potential tumor suppressor gene whose reexpression or re-introduction into malignant cells could, by nature of its inherent pleiotropic effects as a miRNA, represent an important therapeutic tool used to combat a multitude of human cancers.
Export Options
About this article
Cite this article as:
Michel I. Carlos and Malumbres Marcos, MicroRNA-203: Tumor Suppression and Beyond, MicroRNA 2013; 2(2) . https://dx.doi.org/10.2174/22115366113029990016
DOI https://dx.doi.org/10.2174/22115366113029990016 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Prediction and Analysis of Hepatocellular Carcinoma Related Genes Using Gene Ontology and KEGG
Current Bioinformatics The Application of lncRNAs in Cancer Treatment and Diagnosis
Recent Patents on Anti-Cancer Drug Discovery Introduction (Transient Receptor Potential TRP Channels as Therapeutic Drug Targets: Next Round!)
Current Topics in Medicinal Chemistry Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer
Current Molecular Medicine Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Current Pharmacogenomics Recurrent Left Atrial Low-grade Malignant Inflammatory Myofibroblastic Tumor Characterized by Cardiovascular Magnetic Resonance
Current Medical Imaging Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Molecular Targets of FTY720 (Fingolimod)
Current Molecular Medicine Advances in α(v)β(3) Integrin-Targeting Cancer Therapy and Imaging with Radiolabeled RGD Peptides
Current Radiopharmaceuticals Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?
Current Pharmaceutical Design Antimicrobial Peptides and Peptaibols, Substitutes for Conventional Antibiotics
Current Pharmaceutical Design The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
Current Medicinal Chemistry Regulation of Expression and Function of IDO in Human Dendritic Cells
Current Medicinal Chemistry NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design Polyphenols as Potential Therapeutics for Pain and Inflammation in Spinal Cord Injury
Current Molecular Pharmacology One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies Haptotactic Gradients for Directed Cell Migration: Stimulation and Inhibition Using Soluble Factors
Combinatorial Chemistry & High Throughput Screening